Phase 3 Myeloproliferative Neoplasm Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Myeloproliferative NeoplasmPrimary Myelofibrosis

PharmaEssentia150 enrolled1 locationNCT06468033

Recruiting

Phase 3

Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance

Myeloproliferative Neoplasms (MPN)

Siriraj Hospital240 enrolled1 locationNCT06740916